A new study highlights the potential of psilocybin, a psychedelic compound, in treating obsessive-compulsive disorder (OCD) and Tourette’s Syndrome.
Novaliq pursues EMA approval for dry eye disease drug – Pharmaceutical Technology
CyclASol is an eye drop solution for dry eye disease. Credit: Andrii Borodai via Getty Images. The European Medicines Agency (EMA) accepted Novaliq’s marketing authorisation
August 24, 2023